FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5026211000001100: Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
23439901000001115 Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
75208401000001112 Ferrous sulfate 4mg / Silica 1.6mg tablets 50 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Is pack of Ferrous sulphate 4mg / Silica 1.6mg tablets false Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Has active ingredient Ferrous sulfate false Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Has active ingredient Silica false Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Has VMP Ferrous sulphate 4mg / Silica 1.6mg tablets true Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Has specific active ingredient Silica true Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Has specific active ingredient Ferrous sulfate true Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bidor 5% tablets (Weleda (UK) Ltd) 50 tablet Is a True Ferrous sulphate 4mg / Silica 1.6mg tablets 50 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start